SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000919574-20-001657
Filing Date
2020-02-14
Accepted
2020-02-14 15:42:27
Documents
1

Document Format Files

Seq Description Document Type Size
1 d8476876_sc13g-a.htm SC 13G/A 68356
  Complete submission text file 0000919574-20-001657.txt   69947
Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Subject) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88493 | Film No.: 20618879
SIC: 2834 Pharmaceutical Preparations

Mailing Address 510 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10022
Business Address 510 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10022 (212) 231-4932
ARMISTICE CAPITAL, LLC (Filed by) CIK: 0001601086 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A